Momenta Phama (MNTA) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
Research and development: 31.57M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 31.57M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Momenta Phama (NASDAQ: MNTA) reported Q4 EPS of ($0.31), $0.05 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $21.18 million versus the consensus estimate of $23.8 million.
For earnings history and earnings-related data on Momenta Phama (MNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
- Mount Logan unit launches MYGA annuity products, gets B+ AM Best rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
